Capai PLC converts CLNs, issues new shares

Published 07/04/2025, 10:08
Capai PLC converts CLNs, issues new shares

LONDON - Capai PLC announced the conversion of all outstanding convertible loan notes (CLNs) and the issuance of new ordinary shares, a move that has significant implications for the company’s capital structure. Following the conversion, 123 million new ordinary shares of nominal value £0.00001 each (CLN Shares) have been created, eliminating all outstanding CLNs.

In a related action, the company has issued 63.5 million new ordinary shares (Fee Shares) to settle outstanding fees, as per its previous announcement on January 29, 2025. Both the CLN Shares and the Fee Shares, totaling 186.5 million new shares (New Ordinary Shares), are expected to be admitted to the Official List of the Financial Conduct Authority (FCA) and to trading on the London Stock Exchange (LON:LSEG)’s (LSE) main market around 8:00 a.m. on April 11, 2025.

This development follows the company’s March 12, 2025 announcement regarding the listing of Fundraising Shares and Fundraising Warrants, which are now trading on the LSE. The transactions involved participations by Professor Ronjon Nag, Richard Edwards, and Sarah Davy, who are Persons Discharging Managerial Responsibilities (PDMRs) within the company.

With the admission of the New Ordinary Shares, Capai PLC’s total issued share capital will be 3,121,102,336 Ordinary Shares, with the same number of voting rights, as the company does not hold any shares in treasury. This total share count will serve as the denominator for shareholders to calculate changes in their interest in the company’s share capital, in accordance with the FCA’s Disclosure Guidance and Transparency Rules.

The information is based on a press release statement from Capai PLC, which provided details on these corporate actions. The company has not disclosed any further information regarding the strategic rationale behind the conversion of the CLNs or the issuance of the Fee Shares. Shareholders and potential investors are advised to monitor these developments, as they may influence the company’s financial position and stock performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.